118 related articles for article (PubMed ID: 9921920)
21. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
[TBL] [Abstract][Full Text] [Related]
22. Combination of IL-12 gene therapy and CTX chemotherapy inhibits growth of primary B16(F10) melanoma tumors in mice.
Mitrus I; Delić K; Wróbel N; Missol-Kolka E; Szala S
Acta Biochim Pol; 2006; 53(2):357-60. PubMed ID: 16733559
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
Larchian WA; Horiguchi Y; Nair SK; Fair WR; Heston WD; Gilboa E
Clin Cancer Res; 2000 Jul; 6(7):2913-20. PubMed ID: 10914741
[TBL] [Abstract][Full Text] [Related]
24. Antitumour activity of Salmonella typhimurium VNP20047 in B16(F10) murine melanoma model.
Jazowiecka-Rakus J; Szala S
Acta Biochim Pol; 2004; 51(3):851-6. PubMed ID: 15448746
[TBL] [Abstract][Full Text] [Related]
25. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.
Miyagi T; Koshida K; Hori O; Konaka H; Katoh H; Kitagawa Y; Mizokami A; Egawa M; Ogawa S; Hamada H; Namiki M
J Gene Med; 2003 Jan; 5(1):30-7. PubMed ID: 12516049
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach.
Anderson LM; Krotz S; Weitzman SA; Thimmapaya B
Cancer Gene Ther; 2000 Jun; 7(6):845-52. PubMed ID: 10880014
[TBL] [Abstract][Full Text] [Related]
28. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
29. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
[TBL] [Abstract][Full Text] [Related]
30. Regression of established subcutaneous B16-F10 murine melanoma tumors after gef gene therapy associated with the mitochondrial apoptotic pathway.
Prados J; Melguizo C; Ortiz R; Boulaiz H; Carrillo E; Segura A; Rodríguez-Herva JJ; Ramos JL; Aránega A
Exp Dermatol; 2010 Apr; 19(4):363-71. PubMed ID: 19645856
[TBL] [Abstract][Full Text] [Related]
31. Provision of positive and negative selections in retroviral vectors containing the cytosine deaminase gene.
Shiau AL; Yang HM; Wu P; Wu CL
Gene Ther; 1998 Nov; 5(11):1571-4. PubMed ID: 9930312
[TBL] [Abstract][Full Text] [Related]
32. Liposomal formulation of 5-fluorocytosine in suicide gene therapy with cytosine deaminase--for colorectal cancer.
Chaszczewska-Markowska M; Stebelska K; Sikorski A; Madej J; Opolski A; Ugorski M
Cancer Lett; 2008 Apr; 262(2):164-72. PubMed ID: 18291575
[TBL] [Abstract][Full Text] [Related]
33. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates.
Reimer DL; Kong S; Monck M; Wyles J; Tam P; Wasan EK; Bally MB
J Pharmacol Exp Ther; 1999 May; 289(2):807-15. PubMed ID: 10215656
[TBL] [Abstract][Full Text] [Related]
34. Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene.
Ueno M; Koyama F; Yamada Y; Fujimoto H; Takayama T; Kamada K; Naito A; Hirao S; Mukogawa T; Hamada H; Nakajima Y
Anticancer Res; 2001; 21(4A):2601-8. PubMed ID: 11724328
[TBL] [Abstract][Full Text] [Related]
35. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
[TBL] [Abstract][Full Text] [Related]
36. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
[TBL] [Abstract][Full Text] [Related]
37. KDR promoter can transcriptionally target cytosine deaminase suicide gene to cancer cells of nonendothelial origin.
Szary J; Kalita K; Przybyszewska M; Dus D; Kieda C; Janik P; Szala S
Anticancer Res; 2001; 21(5):3471-5. PubMed ID: 11848511
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of tumor growth by interleukin 10 gene transfer in B16(F10) melanoma cells.
Walos S; Szary J; Szala S
Acta Biochim Pol; 1999; 46(4):967-70. PubMed ID: 10824866
[TBL] [Abstract][Full Text] [Related]
39. Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene.
Pastorakova A; Hlubinova K; Altaner C
Neoplasma; 2006; 53(6):478-84. PubMed ID: 17167715
[TBL] [Abstract][Full Text] [Related]
40. [Anti-tumor and bystander effects of cationic liposome-mediated CD/5-FC suicide gene system combined with interferon-gamma in vivo].
Luo Q; Lu YZ; Liu GY; Zhang SE
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1621-5. PubMed ID: 18819882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]